Inhalable nanozymes against pneumonia

Weihang 'Savannah' Zhang¹, Ke Cheng^{2

3}

Affiliations

¹ Department of Biomedical Engineering, Columbia University, New York, NY, USA.
² Department of Biomedical Engineering, Columbia University, New York, NY, USA. ke.cheng@columbia.edu.
³ Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. ke.cheng@columbia.edu.

Weihang 'Savannah' Zhang et al. Nat Mater. 2025 Apr.

. 2025 Apr;24(4):491-492.

doi: 10.1038/s41563-025-02182-1.

Weihang 'Savannah' Zhang¹, Ke Cheng^{2

3}

¹ Department of Biomedical Engineering, Columbia University, New York, NY, USA.
² Department of Biomedical Engineering, Columbia University, New York, NY, USA. ke.cheng@columbia.edu.
³ Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. ke.cheng@columbia.edu.

No abstract available

Conflict of interest statement

Competing interests: The authors declare no competing interests.

1. Kim, S. Y. et al. Nat. Commun. 8, 2247 (2017). - PubMed - PMC
1. Peng, W. et al. Nat. Mater. https://doi.org/10.1038/s41563-024-02041-5 (2024). - DOI - PubMed
1. Zhang, Y. et al. Nat. Rev. Methods Primers 4, 36 (2024).
1. Wang, Z. et al. Adv. Mater. 36, 2210144 (2024).
1. Wang, H. et al. Nat. Biomed. Eng. 6, 882–897 (2022). - PubMed